Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

SAVASAVA
Showing 8 of 23 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in FILANA THERAPEUTICS INC

Bank of New York Mellon Corp holds 20,284 shares of SAVA (FILANA THERAPEUTICS INC), worth $24,138 as of 2026-Q2. The position was decreased (-1.0% shares).

Current Value

$24,138

Current Shares

20,284

Total Value Change

-$3.1M

Total Shares Change

-87,558

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
20,284
-1.0%
$24,1380.0%$2.22
0
2026-Q1
Unchanged
20,481
0.0%
$34,6130.0%$2.22
0
2025-Q4
Increased
20,481
+92.1%
$40,5520.0%$2.03
22
2025-Q3
Unchanged
10,663
0.0%
$31,0280.0%$3.14
0
2025-Q2
Decreased
10,663
-90.4%
$19,2990.0%$1.75
0
2025-Q1
Decreased
110,658
-0.1%
$165,9870.0%$1.65
0
2024-Q4
Increased
110,794
+2.7%
$261,4740.0%$2.40
16
2024-Q3
Decreased
107,842
-23.4%
$3.2M0.0%$28.49
0

Other major holders of SAVA: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used